差分

ナビゲーションに移動 検索に移動
*[https://www.biorxiv.org/content/10.1101/2021.01.18.426984v1.full Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera](※査読前)
*[https://www.medrxiv.org/content/10.1101/2021.01.19.21249840v2.full SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies](※査読前)
|style="vertical-alighnalign:top;"|
*[https://www.medrxiv.org/content/10.1101/2021.01.19.21249840v2.full mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants](※査読前)
*[https://www.biorxiv.org/content/10.1101/2021.01.25.427948v1.full mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants](※査読前)

案内メニュー